CRH French Reference Center for Hemophilia Lyon/LinkedIn
Jun 25, 2026, 15:21
Balancing Therapeutic Progress and Emergency Preparedness in Hemophilia – CRH French Reference Center for Hemophilia Lyon
CRH French Reference Center for Hemophilia Lyon shared a post on LinkedIn:
“A critical challenge in the era of non-factor therapies for hemophilia: ensuring adequate emergency stocks of coagulation factor concentrates across healthcare institutions.
When life-threatening bleeding occurs, every minute matters.
Immediate access to coagulation factor concentrates remains essential for effective emergency management and patient safety—even for patients receiving non-factor therapies.
As the therapeutic landscape continues to evolve, we must ensure that these major advances do not unintentionally compromise the availability of life-saving clotting factor concentrates in emergency settings.”

Stay updated with Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience